You are in: eMedicine Specialties > Pediatrics: General Medicine > Nephrology ProteinuriaArticle Last Updated: Apr 21, 2008AUTHOR AND EDITOR INFORMATION
Author: Ronald J Kallen, MD, Associate Professor, Department of Pediatrics, Northwestern University; Consulting Staff, Department of Pediatrics, Division of Pediatric Kidney Disease, Children's Memorial Hospital of Chicago Ronald J Kallen is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Nephrology, and Society for Pediatric Research Coauthor(s): Watson C Arnold, MD, Director, Department of Pediatric Nephrology, Cook Children's Medical Center Editors: Laurence Finberg, MD, Clinical Professor, Department of Pediatrics, University of California at San Francisco and Stanford University; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Luther Travis, MD, William W Glauser Professor of Pediatrics and Pediatric Nephrology, Department of Pediatrics, Divisions of Nephrology and Diabetes, University of Texas Medical Branch and Children's Hospital; Howard Trachtman, MD, Program Director, Pediatrics Research, Schneider Children's Hospital, Department of Pediatrics, Division of Nephrology, Professor, Albert Einstein College of Medicine; Craig B Langman, MD, The Isaac A Abt, MD, Professor of Kidney Diseases, Feinberg School of Medicine, Northwestern University; Division Head of Kidney Diseases, Children's Memorial Hospital, Chicago Author and Editor Disclosure Synonyms and related keywords: proteinuria, glomerular lesion, kidney disease, glomerulonephropathies, glomerulonephropathy, albuminuria, diabetes mellitus, end-stage renal disease, albumin levels, microalbuminuria, orthostatic proteinuria, hematuria, glomerular filtration barrier, tubular proteinuria, nephrotic syndrome, chronic kidney disease, Dent disease, edema, hypertension, azotemia, failure to thrive, nephrotic-range proteinuria, subnephrotic proteinuria, immunoglobulin A nephropathy, IgA nephropathy, minimal lesion nephrotic syndrome, MLNS, nonorthostatic proteinuria, postinfectious glomerulonephritis, poststreptococcal glomerulonephritis, type 1 diabetes mellitus, type 2 diabetes mellitus, diabetic nephropathy INTRODUCTION
Persistent proteinuria indicates the presence of a glomerular lesion and may also play a central role in the pathogenesis of progression of glomerulonephropathies to end-stage renal disease. Therefore, some consider proteinuria to be nephrotoxic. The current consensus is that lessening the degree of proteinuria is an imperative of renoprotective therapy. Pharmacotherapy is aimed at mitigating glomerular hyperfiltration with the use of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers. The prevalence of proteinuria on a single test of urine is estimated to be 5-15%. Repeated tests should be conducted, perhaps as many as 3 times at weekly intervals. First-voided morning specimens should be used to establish if proteinuria is persistent. The National Kidney Foundation Consensus Panel on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE) reported that, even after 4 tests, 10.7% of children have proteinuria in 1 of 4 specimens.1 However, only 0.1% had positive protein results in all 4 specimens. DETECTION OF PROTEINURIA
The The commonly used dip-and-read test strip (dipstick) mainly detects albumin among the various proteins in urine. This test is sensitive to albumin concentrations as low as 15 mg/dL. However, it is not sufficiently sensitive for detecting albumin in the range of microalbuminuria (ie, albumin excretion of 30-300 mg/d in an adult). The threshold for transition from microalbuminuria to dipstick-detectable albuminuria (300 mg albumin excreted per day in an adult) corresponds to a concentration of 15 mg/dL if the daily urine volume is 2000 mL. This level gives a trace result with the dipstick. Because the most widely used test for detection of proteinuria is the dipstick test, which is actually a test for albumin, the term proteinuria is used to refer to albuminuria in the rest of this discussion. However, the caveat remains that quantitative estimates of proteinuria performed at clinical chemistry laboratories reflect several classes of proteins and yield a result greater than the actual amount of albumin in the specimen. Moreover, recent concepts of the renal handling of albumin, including its degradation within the kidney, suggest that the measurement of albumin excretion as the intact molecule is an underestimate of the actual quantity processed by the kidney subsequent to filtration. The dipstick test is the most convenient method for routine testing and is often the test that causes proteinuria to be first identified in an otherwise asymptomatic individual. The urine should be tested as soon after voiding as possible. pH affects color development of the protein-detecting reagent, which changes color in the presence of albumin. Gradations from light to dark green reflect increasing concentrations of albumin. Dilute urine may clinically mask significant proteinuria. Concentrated urine may suggest clinically significant proteinuria when the actual degree of proteinuria is not severe. If highly dilute or concentrated urine is positive for proteinuria, a more reliable estimate than this is made by using the protein-to-creatinine ratio (see below). A false-positive result may occur if the urine is highly alkaline (pH >8) or if a skin-disinfecting agent, such as chlorhexidine or benzalkonium chloride, contaminates the specimen. The dipstick result may be difficult to read if the urine is abnormally colored because of nitrofurantoin, riboflavin, or azo-containing sulfonamide antimicrobials. The dipstick test for protein provides a crude semiquantitative estimation of protein concentration, with results as follows:
The dipstick color transition between negative and trace may not be easily distinguished. Although colors reflecting heavy proteinuria in the range of 3+ and 4+ are readily discerned, confirming grades 1+ and 2+ using sulfosalicylic acid reagent is advisable. The use of this reagent is also a semiquantitative test based on an estimate of the degree of turbidity. However, it has decreased specificity for albumin. In any child with a positive dipstick result greater than trace for protein, a quantitative estimate of proteinuria should be determined. In older children and adolescents, a 24-hour collection may be performed. The usual rate of excretion of protein is somewhat higher in children than in adults, perhaps as much as 200 mg/d in older children. However, referencing 24-hour protein excretion to the patient's body size is preferable; the reference range is less than 100 mg/m2/d. In this context, protein refers to the aggregate of protein in urine as determined by using the usual assay in the clinical chemistry laboratory. In healthy adults, albumin accounts for about 15% of the total protein in urine. Other plasma proteins account for about 35%. Approximately 50% is due to protein originating in the kidney and urinary tract, primarily Tamm-Horsfall protein (also referred to as uromodulin). In young children, quantitatively assaying the degree of proteinuria by using a single randomly voided specimen is most convenient. The concentrations of protein and creatinine the clinical chemistry laboratory reports are used to calculate the protein-to-creatinine ratio. The units of measurement must be the same. If protein is reported as grams per liter and creatinine as milligrams per deciliter, either unit should be converted to the other before the protein-to-creatinine ratio is calculated. A reference ratio for children older than 2 years is less than 0.2 mg protein per milligram of creatinine. A reference value for infants aged 6-24 months is less than 0.5 mg protein per milligram of creatinine. One caveat is that the commonly reported norms for protein-to-creatinine ratio are based on average muscle mass and creatinine production, which may not be the case in poorly nourished individuals. A dip-and-read test strip is now commercially available for the quantitation of the protein-to-creatinine ratio by using an optical analyzer (Multistix PRO Reagent Strips, Bayer Diagnostics, Transient, low-grade proteinuria may occur in a child with fever or when urine is tested immediately after the patient engages in strenuous physical activity. In these instances, the urine should be tested again after fever subsides, or, if the urine was positive for protein shortly after athletic competition, it should be tested again 2-3 days later. Evaluation for orthostatic proteinuria may proceed in these circumstances too. ORTHOSTATIC PROTEINURIA
Under most circumstances, urine for routine testing is collected in the physician's office. Although orthostatic proteinuria does not generally persist beyond the third decade of life, testing for proteinuria on an annual basis is prudent, especially because both pathologic and physiologic proteinuria (ie, the small amount of protein normally present in urine) also has an orthostatic component. If the first-voided morning specimen has a 1+ or greater reaction for protein, further studies are indicated. MECHANISMS OF PROTEINURIA
Reviews of albumin processing by the kidney have brought to the forefront new concepts about the mechanism and pathologic significance of proteinuria.4, 5, 6, 7, 8 The standard model has held that proteinuria is a consequence of increased permeability of the glomerular filtration barrier to plasma proteins. The concept of charge selectivity of the glomerular capillary wall is de-emphasized by recent data, whereas molecular size selectivity is reaffirmed.9 Reports suggest that quantitative changes in protein excretion have less to do with alterations in the barrier function of the glomerulus and more to do with postglomerular processing of filtered proteins, especially albumin, by the proximal tubule. As a consequence, conventional measurements of albuminuria, which fail to detect peptide fragments arising from albumin degradation, underestimate the actual amount of albumin processed by the proximal tubule. According to one estimate, a conventional measurement of SIGNIFICANCE OF PROTEINURIA
Proteinuria generally indicates an alteration in the permeability and selectivity properties of the aggregate glomerular filtration barrier, which encompasses the 3 major components of the glomerular capillary wall: epithelial cell foot processes, glomerular basement membrane, and endothelial cell layer. Until recently, the fixed negative electrostatic charge in the sialoprotein coating of the epithelial foot-process layer and glomerular basement membrane was considered an important determinant of the permselectivity of the filtration barrier, limiting delivery of serum albumin to the glomerular filtrate in the absence of disease. However, recent research suggests that molecular size, rather than electrostatic charge interaction, is the key determinant in restricting passage of protein across the filtration barrier. Nevertheless, the amount of protein in the urine does not simply reflect altered permeability of the glomerular capillary wall. Considerable tubular resorption of filtered albumin is also present, as mentioned above, and kidney disease may also affect this process. The presumption that proteinuria is solely due to alterations of the glomerular filtration barrier may not be true in kidney diseases that affect albumin transport across the tubule. In fact, a healthy adult filters nearly 5400 mg of albumin per day. The amount excreted is much less, about 30 mg per day. Although this discussion focuses on the incidental finding of pathologic proteinuria in an apparently well child, urine should always be tested for protein in any child with hematuria, edema, hypertension, azotemia, failure to thrive, or abnormal images of the kidneys and urinary tract. Although grossly bloody urine commonly produces a positive result for protein, the dipstick test is relatively insensitive to free hemoglobin and does not react with intact erythrocytes. The positive reaction for protein associated with gross hematuria is due to plasma albumin that accompanies erythrocytes into the urine. The amount of plasma albumin that accompanies erythrocytes into the urine in 1 mL of whole blood in 100 mL of urine produces only a trace reaction (if none of the albumin is reabsorbed). High grades of proteinuria detected on dipstick testing of grossly bloody urine should not be ignored because the finding may reflect an underlying glomerulonephropathy. NEPHROTIC AND SUBNEPHROTIC RANGE OF PROTEINURIA
Distinguishing nephrotic-range proteinuria from nonnephrotic (or subnephrotic) proteinuria is clinically useful. In adults, nephrotic-range proteinuria refers to excretion of more than 3-3.5 g of protein per 24 hours or a protein-to-creatinine ratio that exceeds 2.5-3 in a random specimen.11 In adults, the albumin-to-creatinine ratio corresponds to the 24-hour albumin excretion in a roughly linear manner. For example, a ratio of 3 is predictive of an excretion of about 3 g of protein in 24 hours. In children, nephrotic-range proteinuria is greater than 1000 mg/m2/d when body surface area is used as a reference. For a typical 2-year-old child with idiopathic minimal lesion nephrotic syndrome (MLNS), excretion of 500-600 mg per 24 hours constitutes nephrotic-range proteinuria. By comparison, excretion of 1000 mg of protein per day is nephrotic-range proteinuria in an average-sized child aged 9-10 years. Proteinuria in the subnephrotic range does not distinguish a relatively benign nonprogressive glomerular lesion from a relatively serious type of glomerulonephritis. However, prognostic estimates based solely on the degree of proteinuria are often difficult, and kidney biopsy may be necessary for further definition. One example is immunoglobulin A (IgA) nephropathy, which often manifests as intermittent episodic synpharyngitic hematuria or with the incidental finding of microscopic hematuria. Nephrotic-range proteinuria portends an ominous prognosis. However, subnephrotic proteinuria in IgA nephropathy is of uncertain significance, and renal biopsy is often needed. When not orthostatic or transient, proteinuria always indicates glomerular pathology. Glomerular changes may be due to inflammation (any one of several forms of glomerulonephritis) or may be subtle and seen only on electron microscopy; an example is effacement of epithelial cell foot processes, as observed in the most common cause of nephrotic syndrome in children (ie, MLNS). See Nephrotic Syndrome for more information. In this instance, the earliest clinical manifestation can be fluctuating degrees of periorbital or facial edema. In many instances, allergy is diagnosed and treated with antihistamines. The urine should always be tested in any child with edema, no matter how subtle the findings are. Nephrotic-range proteinuria may also be the harbinger of focal segmental glomerulosclerosis, which has become increasingly common as a cause of idiopathic nephrotic syndrome. Early recognition and prompt treatment with steroids or other immunomodulator drugs may induce a remission; although, in many instances, the condition is steroid resistant. The distribution of types of protein in the urine varies among the glomerulonephropathies, depending on the extent of altered glomerular permeability. MLNS is a prime example of selective proteinuria. Albumin accounts for much of the excreted protein to the exclusion of high molecular weight plasma proteins. Glomerular lesions with florid inflammatory changes result in nonselective proteinuria, wherein albumin-sized molecules are accompanied by larger proteins, such as immunoglobulins. However, albumin is a sensitive marker of glomerular proteinuria, and the dipstick test primarily detects this protein. This detection is convenient because high molecular weight proteinuria is only rarely significantly greater than albumin excretion in children; this finding leads to an underestimation of the severity of proteinuria. In general, the incidental finding of subnephrotic nonorthostatic proteinuria without hematuria in an apparently healthy child may be monitored in the office setting by means of periodic quantitative estimates, perhaps obtained every 4-6 months. If a trend for increasing proteinuria that exceeds 300 mg/d/m2 or a protein-to-creatinine ratio of 0.5-1 in a first-voided specimen emerges, or if the threshold to the nephrotic range is crossed, renal biopsy is appropriate for histologic diagnosis and prognostic evaluation. Although the classic form of postinfectious (often poststreptococcal) glomerulonephritis may not be observed as frequently as in the past, it is generally a benign, self-limited condition. It is rarely accompanied by nephrotic-range proteinuria. Proteinuria in this instance may persist during the first few weeks of illness but then rapidly resolves. Periodic urine testing to establish complete resolution should be conducted. If low-grade proteinuria persists beyond 12 months after diagnosis, renal biopsy should be considered. Proteinuria may originate from a unilateral diseased kidney in the presence of an apparently normal contralateral kidney, as with reflux nephropathy or with a hypoplastic or dysplastic kidney. However, if heavy proteinuria is found, evaluation of the presumably normal contralateral kidney should be considered. Some filtration of low molecular weight proteins (eg, β2 microglobulin, retinal-binding protein, small peptides) occurs. The proximal tubular cells reabsorb most of these filtered proteins. However, modest, low-grade proteinuria may occur in certain congenital metabolic tubulopathies, such as Fanconi syndrome or X-linked recessive nephrolithiasis with kidney failure that results from a mutation in the CLCN5 gene on chromosome 11 (Dent disease). A high grade of proteinuria, approaching the nephrotic range, may occur in a nonglomerular disease, as is seen in some instances of acute tubulointerstitial nephritis. Because dipstick testing is relatively specific for albumin, low molecular weight (tubular) proteinuria may not be detected. If tubular proteinuria is suspected, specific assays for the individual proteins are available in most hospital or commercial laboratories. PROTEINURIA IN DIABETES MELLITUS
Proteinuria in children and adolescents with diabetes mellitus has special significance. Once established, proteinuria may herald the inevitable progression of diabetic nephropathy. Poor glycemic control, as reflected in an elevated hemoglobin A1C concentration, is a major risk factor for diabetic nephropathy. The earliest indicator of glomerular damage is microalbuminuria, which is below the threshold of detection by the usual dipstick test for proteinuria. ACE inhibitors and angiotensin-receptor blockers have come into widespread use for treatment of early stages of disease, in either type 1 or type 2 diabetes mellitus, before an overt nephrotic syndrome emerges. Because evidence indicates that early intervention may delay or forestall progression of diabetic nephropathy (evidence derived from studies of type 1 diabetes mellitus), all children and adolescents with type 1 or type 2 diabetes mellitus should undergo annual monitoring for microalbuminuria, a marker for identifying an individual at risk for diabetic nephropathy. A person with diabetes mellitus should begin treatment with an ACE inhibitor or angiotensin-receptor blocker when microalbuminuria is documented. The initiation of one of these agents as a preemptive measure of renoprotective therapy before microalbuminuria emerges is currently practiced by some specialists, especially if the hemoglobin A1C is consistently elevated above 8%. The dilemma in this instance is that many people with diabetes mellitus may not have progressive disease, and the uncertain risk, if any, of long-term drug administration remains incompletely understood. Microalbuminuria is not only a harbinger of kidney damage as a consequence of suboptimal glycemic control. A more expansive view is that it is a marker of endothelial cell injury and is now considered a risk factor for cardiovascular disease. FURTHER EVALUATION OF PROTEINURIA
The detection of persistent proteinuria (>1+ or protein-to-creatinine ratio of >0.2) in an apparently well child is a signal for potentially serious underlying kidney disease. THE INJURY POTENTIAL OF PROTEINURIA
Most chronic nephropathies that appear to be primary glomerular disorders are invariably accompanied by tubulointerstitial disease, which may have a more ominous impact on prognosis than the glomerular lesion. The pathogenesis of tubulointerstitial mononuclear cell infiltration, inflammation, tubular atrophy, and fibrosis has not been clear. However, a concept has emerged that the high rate of albumin trafficking in the proximal tubule during the course of proteinuric kidney diseases results in protein overload and injury to the tubular cells. The mechanism of such injury is not clear, but generation of reactive oxygen species and consequent oxidative injury has been proposed as one explanation. TREATMENT
Proteinuria is a marker of parenchymal injury in kidney disorders of diverse etiologies. Primary treatment of most disorders by immunomodulator medications is empiric, and a salutary effect is presumed to have occurred if a diminution of proteinuria is observed. In this sense, treatments aimed at the putative mechanism of the disorder, often immune mediated, also treat the proteinuria. RESEARCH
Proteinuria is an essential marker of kidney disease. However, conventional assays by the clinical laboratory do not distinguish among different classes of proteins present in the urine. Research is now underway to characterize urinary protein excretion by means of proteomic analysis. Emerging data suggests that a proteomic “fingerprint” of the spectrum of urinary proteins will ultimately lead to earlier detection of a pattern of progression and provide markers for assessing pharmacotherapy interventions to mitigate progression of chronic kidney disease. CONCLUSION
Because most forms of kidney disease with glomerular pathology can become chronic and progressive, the Kidney Disease Outcomes Quality Initiative Guidelines of the National Kidney Foundation emphasize early detection of proteinuria and initiation of therapies that preserve kidney function. Recommendations for the evaluation of proteinuria in children mentioned in this discussion are based on the consensus panel sponsored by the National Kidney Foundation.1 REFERENCES
Article Last Updated: Apr 21, 2008 |